Market Indices


Latest News

Following are the Top 5 companies based on their one-day percentage...

January 20, 2026   IMMR 1.39%

Barclays analyst issues OVERWEIGHT recommendation for CRVS on January 20,...

January 20, 2026   CRVS 167.08%

from Mizuho Securities issued a price target of $20.00 for...

January 20, 2026   CRVS 167.08%

Sean Lee from H.C. Wainwright issued a price target of $27.00...

January 20, 2026   CRVS 167.08%

Lifecore Biomedical, Inc. (LFCR) confirmed earnings release on January 20, 2026,...

January 20, 2026   LFCR 0.43%


Price Targets

from Mizuho Securities issued a price target of $20.00 for CRVS on 2026-01-20 17:33:14.The adjusted price target was set to $20.00.At the time of the announcement, CRVS...

January 20, 2026   CRVS 167.08%

Sean Lee from H.C. Wainwright issued a price target of $27.00 for CRVS on 2026-01-20 16:00:41.The adjusted price target was set to $27.00.At the time of the announcement,

January 20, 2026   CRVS 167.08%

Michael Latimore from Northland Securities issued a price target of $16.00 for ONDS on 2026-01-20 14:05:15.The adjusted price target was set to $16.00.At the time of the announcement,

January 20, 2026   ONDS 7.11%

from Lake Street issued a price target of $19.00 for ONDS on 2026-01-20 13:44:42.The adjusted price target was set to $19.00.At the time of the announcement, ONDS...

January 20, 2026   ONDS 7.11%

Ben Haynor from Lake Street issued a price target of $5.50 for BFLY on 2026-01-20 13:43:27.The adjusted price target was set to $5.50.At the time of the announcement,

January 20, 2026   BFLY -1.44%



Market Movers

Top Gainers (%)
NVNO
enVVeno Medical Corporati
11.66
3,309.36%
CRVS
Corvus Pharmaceuticals, I
21.50
167.08%
ACRS
Aclaris Therapeutics, Inc
4.47
70.61%
MYPSW
MYPSW
0.01
68.92%
WGSWW
WGSWW
0.04
42.00%
SJ
Scienjoy Holding Corporat
1.08
20.54%
MASS
908 Devices Inc.
6.57
20.02%
TYGO
Tigo Energy, Inc.
3.49
18.31%

Annual/Quarterly Reports Summary

In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...

November 6, 2024   AIP -5.07%

In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...

November 6, 2024   EOSEW -34.96%

In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...

November 6, 2024   EOSE -0.17%

In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...

November 5, 2024   STOK -0.58%

In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...

November 5, 2024   BSVN -2.47%